Want to see JP:4102 full AI Analyst Report?
Maruo Calcium Co., Ltd. (4102) AI Stock Analysis
Maruo Calcium Co., Ltd.
(TSE/TYO:4102)
Score of 70 reflects a solid financial foundation, positive technical trends, and compelling valuation. The company's strong balance sheet and improved cash flow are key strengths, while sluggish revenue growth remains a concern. The bullish price trend and undervalued metrics support a favorable outlook.
Maruo Calcium Co., Ltd. (4102) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 3.13B
- Dividend Yield
- 4.08%
- Average Volume (3M)
- 627
- Price to Earnings (P/E)
- 8.7
- Beta (1Y)
- 0.02
- Revenue Growth
- 3.88%
- EPS Growth
- 310.93%
- Country
- Japan
- Employees
- 239
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals
Maruo Calcium Co., Ltd. Business Overview & Revenue Model
Company Description
Maruo Calcium Co., Ltd., a Japan-based firm, specializes in the manufacturing and sale of diverse calcium carbonate products and various other industrial raw materials. Its comprehensive product line includes multiple forms of calcium carbonate, such...
How the Company Makes Money
Maruo Calcium primarily makes money by manufacturing calcium-based materials and selling them to business customers (B2B). Revenue is generated from (1) product sales of calcium compounds and related chemical/industrial materials, where earnings depe...
Maruo Calcium Co., Ltd. Financial Statement Overview
Summary
Revenue decline offset by improved net income; strong balance sheet with low debt; robust operating cash flow. Overall financial health is solid with recent improvements.
Income Statement
58NeutralBalance Sheet
70PositiveCash Flow
68Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.05B | 12.64B | 12.84B | 12.89B | 12.59B | 11.57B |
| Gross Profit | 2.29B | 2.19B | 2.12B | 2.24B | 2.27B | 2.11B |
| EBITDA | 726.58M | 671.13M | 524.47M | 632.42M | 515.25M | 725.98M |
| Net Income | 359.33M | 293.51M | 148.63M | 249.24M | 117.14M | 190.80M |
Balance Sheet | ||||||
| Total Assets | 17.07B | 17.13B | 16.87B | 17.01B | 16.99B | 15.64B |
| Cash, Cash Equivalents and Short-Term Investments | 2.50B | 2.65B | 2.39B | 3.15B | 3.65B | 3.26B |
| Total Debt | 2.27B | 2.42B | 2.31B | 2.04B | 2.66B | 1.99B |
| Total Liabilities | 6.56B | 6.84B | 6.66B | 7.02B | 7.29B | 6.34B |
| Stockholders Equity | 10.31B | 10.08B | 9.80B | 9.62B | 9.30B | 8.90B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 414.29M | -617.93M | 207.05M | -225.65M | 203.10M |
| Operating Cash Flow | 0 | 959.18M | 246.92M | 508.99M | 464.80M | 529.34M |
| Investing Cash Flow | 0 | -650.52M | -1.17B | -345.73M | -745.35M | -441.94M |
| Financing Cash Flow | 0 | -62.26M | 116.41M | -762.08M | 606.48M | -478.57M |
Maruo Calcium Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4102, the sentiment is Positive. The current price of 1469.00 is above the 20-day moving average (MA) of 1448.30, above the 50-day MA of 1448.38, and above the 200-day MA of 1423.00, indicating a bullish trend. The MACD of 1.82 indicates Negative momentum. The RSI at 61.91 is Neutral, neither overbought nor oversold. The STOCH value of 74.08 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4102.
Maruo Calcium Co., Ltd. Peers Comparison
Overall Rating
JP:815874.5Outperform
JP:410270Outperform
JP:409369Neutral
JP:404064Neutral
JP:496044Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 75Outperform | JPY 27.80B | 10.58 | ― | 3.55% | 5.71% | 75.41% | |
| 70Outperform | JPY 3.28B | 8.71 | ― | 4.08% | 3.88% | 310.93% | |
| 69Neutral | JPY 14.44B | 11.14 | ― | 3.39% | -0.22% | 4.42% | |
| 64Neutral | JPY 10.11B | 2.90 | ― | 1.50% | 0.56% | 238.99% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 44Neutral | JPY 8.17B | 26.66 | ― | 1.01% | -5.34% | 113.57% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4102 | Maruo Calcium Co., Ltd. | 1469.00 | 108.28 | 7.96% | |
| JP:4040 | NANKAI CHEMICAL COMPANY LIMITED | 4340.00 | 1695.07 | 64.09% | |
| JP:4093 | Toho Acetylene Co., Ltd. | 413.00 | 68.03 | 19.72% | |
| JP:4960 | Chemipro Kasei Kaisya,Ltd. | 497.00 | 136.71 | 37.94% | |
| JP:8158 | Soda Nikka Co., Ltd. | 1295.00 | 333.23 | 34.65% |
Maruo Calcium Co., Ltd. Corporate Events
Maruo Calcium Delivers Profit Rebound but Guides Cautious Full-Year Outlook
Maruo Calcium Co., Ltd. reported a strong recovery in its first quarter for the fiscal year ending March 31, 2027, with net sales rising 13.6% year-on-year to ¥3,397 million. Profit attributable to owners of the parent jumped sharply to ¥66...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 17, 2026